Delivery Order SPE2DB24D2205-SPE2DB24FDVYQ

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXCOM G6 SENSOR 3S medical devices. The contract has a ceiling value of $2,719.26 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The U.S. Defense Logistics Agency (DLA) awarded a $1,512.60 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of DEXCOM G6 SENSOR 3S medical devices. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which allows for the procurement of a comprehensive range of pharmaceutical and medical commodities to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,221.54 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of March 6, 2024, is for the delivery of DEXCOM G6 SENSOR 3S medical devices. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
The U.S. Defense Logistics Agency (DLA) awarded a $1,255.19 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DEXCOM G7 SENSORS and has an ultimate completion date of April 4, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,400.00 contract is for the delivery of DEXCOM G6 SENSOR 3S medical supplies to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This contract award is for the delivery of DEXCOM G6 SENSOR 3S medical devices to the Defense Logistics Agency (DLA). The $1,212.65 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 17, 2024. While the original solicitation is not provided, the award indicates that the DLA has an Indefinite Delivery Contract (IDC) with AmerisourceBergen valued at...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $5,216.80 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DEXCOM G6 SENSOR 3S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $56,753.19 firm fixed-price contract is for the supply of DEXCOM G6 SENSOR 3S medical devices. The contract has a period of performance through June 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,766.74 firm fixed-price delivery order is for the supply of DEXCOM G6 SENSOR 3S medical devices. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DEXCOM G6 SENSORS 3S. This $3,304.58 contract has an ultimate completion date of April 10, 2024 and is not associated with any set-aside designation. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVYQ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,262.32 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of DEXCOM G6 SENSOR 3S medical devices, with a period of performance ending on June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure essential pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 9/23/24, 9:49 AM